Key statistics dashboard for Impact BioMedical Inc. (IBO). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions.
Stock Data
| Price | $0.50 |
| Market Cap | $54M |
| Beta | 3.86 |
| Exchange | AMEX |
| Country | US |
Valuation Multiples
| P/E Ratio | -5.42 |
| Price / Book | 5.30 |
| P/S | 1629.64 |
| P/FCF | -112.28 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | -1111.43% |
| EBIT Margin | -4411.43% |
| EBITDA Margin | -1145.71% |
| Operating Margin | -14562.86% |
| Net Margin | 2254.29% |
Financial Health
| Current Ratio | 0.16 |
| Quick Ratio | 0.13 |
| Cash Ratio | 0.00 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.00% |
| Interest Coverage | -19.45 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 0.13 |
| Cash per share | 0.00 |
| FCF per share | -0.00 |
| Tangible Book Value per share | -0.02 |
| Dividend per share | 0.00 |
Related companies: ADIL · AIM · BCLI · CYCN · MLEC · NRSN · QNRX
Explore sector: Healthcare · Biotechnology
More sections of IBO: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks